However, the company reported a 72 percent revenue increase to $9.1 million in the fourth quarter and a 96 percent increase to $30.1 million in 2011. Over the past year, the company acquired assets of Robinson MedSurg and entered into a $31 million equity purchase agreement with Lincoln Park Capital Fund.
During the fourth quarter, the company completed a two-year study of its OsteoSponge, showing equivalence to rhBMP-2 in spinal fusion.
More Articles on Orthopedic Devices:
10 Milestones for Spine Devices
Global Orthopedic Prosthetics to Reach $23.5B by 2017
15 of the Most Profitable Orthopedic & Spine Device Companies in 2011
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
